Cargando…
"Bronchial Artery Delivery of Viral Vectors for Gene delivery in Cystic Fibrosis; Superior to Airway Delivery?"
BACKGROUND: Attempts at gene therapy for the pulmonary manifestations of Cystic Fibrosis have relied mainly on airway delivery. However the efficiency of gene transfer and expression in the airway epithelia has not reached therapeutic levels. Access to epithelial cells is not homogenous for a number...
Autores principales: | Bakhai, Ameet, Sheridan, Desmond J, Coutelle, Charles C |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2002
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC107842/ https://www.ncbi.nlm.nih.gov/pubmed/11929614 http://dx.doi.org/10.1186/1471-2466-2-2 |
Ejemplares similares
-
Transcatheter drug delivery through bronchial artery for COVID-19: is it fiction or could it come true?
por: Zaitoun, Mohamed M. A., et al.
Publicado: (2020) -
Lysolipid containing liposomes for transendothelial drug delivery
por: Koklic, Tilen, et al.
Publicado: (2012) -
Target drug delivery system as a new scarring modulation after glaucoma filtration surgery
por: Shao, Tingting, et al.
Publicado: (2011) -
Allele frequency for Cystic fibrosis in Indians vis-a/-vis global populations
por: Bepari, Karnajit Kumar, et al.
Publicado: (2015) -
The Bacterial Biofilm Matrix as a Platform for Protein Delivery
por: Absalon, Cedric, et al.
Publicado: (2012)